Light therapy and memory training for amnestic mild cognitive impairment
Tests light therapy plus memory training in amnestic mild cognitive impairment.
Key facts
- Who runs it
- Uskudar University
- Where
- Türkiye2 sites in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 30 Mar 2024
- Planned end
- Oct 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active transcranial Photobiomodulation
- sham transcranial Photobiomodulation
- Cognitive Rehabilitation
- Record updated
- 17 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 55 or older with amnestic mild cognitive impairment (aMCI), a memory problem greater than normal aging. It tests a light-based brain treatment together with memory training.
- Age
- 55 years or older
- Sex
- All sexes can join
- Disease stage
- A diagnosis of amnestic mild cognitive impairment (aMCI)
Main reasons for not taking part
- Having a neurological disorder (a disease of the brain or nerves)
- Having a severe mental health disorder
- Having a pacemaker or other implanted medical device that is not safe in an MRI scanner
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age 55 years or older
- Diagnosis of amnestic Mild Cognitive Impairment (aMCI)
Who cannot take part
- Presence of a neurological disorder
- Presence of a severe psychiatric disorder
- Having a pacemaker or other implanted medical device that is not MRI-compatible
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if transcranial photobiomodulation (t-PBM), a light-based brain therapy, can help improve memory and cognitive skills in older adults with amnestic mild cognitive impairment (aMCI). This condition involves memory problems that are greater than normal aging and may increase the chance of developing Alzheimer's disease.
Read full original descriptionShow less
The main questions this study aims to answer are:
1. Does t-PBM, when used together with cognitive training, improve memory and cognitive skills? 2. Does t-PBM change how certain brain areas communicate with each other, especially in the default mode network (DMN)?
Researchers will compare:
t-PBM plus cognitive training to sham (inactive) t-PBM plus the same cognitive training to see if the active light treatment leads to better cognitive improvement and healthier brain activity.
Participants will:
* Provide a blood sample so the research team can create a genetic profile; * Complete cognitive tests before and after the 4-week program; * Meet with a dietitian before and after the program so the research team can make sure diet stays consistent and does not influence brain results; * Have a brain fMRI scan before and after treatment to measure brain connectivity changes; * Take part in eight sessions of cognitive training; * Receive either active t-PBM or sham t-PBM during these sessions.
The 2 groups in the trial
- Intervention Arm: Active TreatmentTreatment being tested
Participants in this arm will receive active transcranial photobiomodulation delivered at gamma frequency while simultaneously participating in a structured cognitive rehabilitation session. The photobiomodulation device will be placed on the participant's head and will operate continuously for 20 minutes during each session. Cognitive rehabilitation tasks will be administered throughout the stimulation period to enhance cognitive engagement. This combined intervention will be applied across all scheduled treatment sessions.
Treatment: Active transcranial Photobiomodulation and Cognitive Rehabilitation
- Control Arm: Sham/PlaceboSham treatment, for comparison
Participants in this arm will receive sham transcranial photobiomodulation while completing the same cognitive rehabilitation session provided to the experimental group. The device will be placed on the participant's head and will appear to operate normally; however, no active light output will be delivered. Each session lasts 20 minutes, during which participants complete standardized cognitive rehabilitation tasks. Session frequency, duration, and rehabilitation procedures are identical to the experimental arm to maintain blinding and ensure comparable conditions.
Treatment: sham transcranial Photobiomodulation and Cognitive Rehabilitation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effects of Transcranial Photobiomodulation (t-PBM) on Cognitive Performance and Functional Brain Connectivity in Patients With Mild Cognitive Impairment and the Role of Genetic Factors
- Plain-language title
- Light therapy and memory training for amnestic mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 17 December 2025